KCTD12 antibody
Contáctenos para saber el precio
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
KCTD12 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab04503
tested applications
ELISA, WB, IF
Description
Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization(By similarity).
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | potassium channel tetramerisation domain containing 12 (KCTD12) |
| Host | Rabbit |
| Reactivity | Human, Mouse, Rat |
| Recommended Dilution | WB: 1:500-1:2000; IF: 1:20-1:200 |
| Clonality | polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Observed MW | 40 kDa |
| Purity | ≥95% as determined by SDS-PAGE |
| Purification | Immunogen affinity purified |
| Size 1 | 100µg |
| Form | liquid |
| Tested Applications | ELISA, WB, IF |
| Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| UniProt ID | Q96CX2 |
| Gene ID | 115207 |
| Alias | KCTD12,PFET1,PFETIN,C13orf2 |
| Background | Antibody anti-KCTD12 |
| Status | RUO |
| Note | Mol. Weight 40 kDa |
Descripción
KCTD12 is a member of the potassium channel tetramerization domain (KCTD) family and functions as an auxiliary subunit of GABA-B receptors. KCTD12 modulates GABA-B receptor signaling by accelerating activation and desensitization kinetics, fine-tuning inhibitory neurotransmission in the central nervous system. It is predominantly expressed in brain regions involved in cognition, sensory processing, and motor control, where it regulates synaptic inhibition and neuronal excitability. KCTD12 also interacts with various proteins through its BTB/POZ domain, contributing to cellular processes like ubiquitination and transcriptional regulation. Beyond its role in neurotransmission, KCTD12 has been implicated in cancer, particularly gastrointestinal stromal tumors (GISTs), where its expression influences tumor cell proliferation and survival. In psychiatric disorders, such as anxiety and depression, altered KCTD12 expression disrupts GABA-B receptor-mediated signaling, impairing inhibitory balance in neural circuits. Its role as a GABA-B receptor modulator and involvement in protein-protein interactions highlights KCTD12 as a key regulator of neuronal function and a potential therapeutic target for neurological disorders and cancer.
Related Products
KCTD12 antibody
Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization(By similarity).
Ver Producto
Potassium Channel Tetramerization Domain Containing 12 (KCTD12) Antibody
KCTD12 Antibody is a Rabbit Polyclonal antibody against KCTD12.
Ver Producto
Potassium Channel Tetramerization Domain Containing 12 (KCTD12) Antibody
Potassium Channel Tetramerisation Domain Containing 12 Antibody is a Rabbit Polyclonal antibody against Potassium Channel Tetramerisation Domain Containing 12.
Ver Producto